| Application no. and date | 21761883.4 (espacenet) (Federated) (European Patent Register), 20210224 | | Patent/reg. no. and date | DK/EP 4069254, 20240911 | | Publication date | 20221012 | | Priority no. and date | US 202062981304 P, 20200225 | | EP pub. no. and date |
EP 4069254 20221012 | | Effective date | | | Applicant/owner | Otsuka Pharmaceutical Co., Ltd., 2-9, Kanda Tsukasa-machi
Chiyoda-ku
Tokyo 101-8535, JP | | Applicant ref. no. | P85283DK01 | | Inventor | DAVAR, Nipun, 868 Piemonte Drive
Pleasanton, California 94566, US,
OGANESIAN, Aram, 2532 Molinaro Way
Dublin, California 94568, US,
KOU, Jim Hwaicher, 1558 Larkin Avenue
San Jose, California 95129, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/706 (2006.01) , A61K 31/7068 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | | Title | FASTE ORALE DOSERINGSFORMER OMFATTENDE DECITABIN OG CEDAZURIDIN | | Int. application no. | US2021019310 | | Int. publication no. | WO2021173598 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
